A notice seeking public input now under Office of Management and Budget review suggests the FDA wants to consolidate its ...
Bausch + Lomb board chairman and Bausch Health CEO Thomas Appio has been appointed interim CEO effective immediately. Bausch ...
The US FDA has issued an early alert concerning connectivity issues with the Philips Lumify ultrasound system that may ...
A new analysis tracks how the EU’s clinical research environment has evolved over more than a decade, amid a new regulatory ...
Outlook Therapeutics has promoted to the role of chief commercial officer Greg DiPasquale – who has previously been ...
The National Health Service (NHS) in England will pilot whether easing local affordability pressures can turn NICE approval ...
US-based Thyme Companies has announced the launch of biosimilars venture Thyme Therapeutics to establish a new sustainable ...
After a slower beginning of the calendar year, NDA and BLA approval activity jumped in July, August and September, which pushed its averages back to historical norms.
Speakers at the ABHI Digital Health Conference reflected on the UK MHRA’s future as AI changes the game both externally and ...
Investors described a relay in which the US leads early science, China leads mid-stage development and the US returns for ...
ODSP director Cara Welch discussed NDIN guidance, drug exclusion provision, “old” ingredient list, defining dietary ...
Raynovent's first-in-class, biweekly injected GLP-1/GIP dual agonist shows 22% body weight reduction at highest dose at 52 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results